Investigations are deepening into the potential involvement
of Goldman Sachs Group Inc. employees in the high-profile Galleon Group
insider-trading ring, the Wall St Journal reports.
U.S. prosecutors and securities regulators are investigating
whether a senior Goldman investment banker gave Galleon hedge-fund traders
advance word of pending health-care deals, according to people familiar with
the matter. The banker, whom the people identified as Matthew Korenberg, is a
San Francisco-based managing director for Goldman, a senior post.
Among the merger deals being scrutinized by Los Angeles
federal prosecutors and the Securities and Exchange Commission is the 2009
acquisition by Abbott Laboratories of Advanced Medical Optics, a Santa ….
No comments:
Post a Comment